A/Prof Amanda Gwee
A/Prof Amanda Gwee
Details
Role
Group Leader/Clinician-Scientist Fellow
Research area
Infection, Immunity and Global Health
Group
Antimicrobials
Associate Professor Amanda Gwee MBBS FRACP DTMH PhD is the Leader of the Antimicrobials Group at Murdoch Children's Research Institute. She is a general paediatrician, infectious diseases physician, clinical pharmacologist, and Clinical Lead of Research in the Department of General Medicine at The Royal Children’s Hospital Melbourne. In addition, she is an Associate Professor in the Department of Paediatrics, at the University of Melbourne.
Her research program focuses on optimising antimicrobial use and access in children and includes national and international clinical trials, pharmacokinetic/pharmacodynamic studies, and cohort studies. Amanda is passionate about improving medication use in children and is involved in several international guideline/expert groups (European Society for Paediatric Infectious Diseases, WHO, Therapeutic Guidelines). She created and leads the Australasian KIDS DOSE consortium, a network of paediatric clinician-researchers across 17 hospital/research institutions in Australia and New Zealand, dedicated to improving equity in access to optimal antimicrobial use in children.
Her research program focuses on optimising antimicrobial use and access in children and includes national and international clinical trials, pharmacokinetic/pharmacodynamic studies, and cohort studies. Amanda is passionate about improving medication use in children and is involved in several international guideline/expert groups (European Society for Paediatric Infectious Diseases, WHO, Therapeutic Guidelines). She created and leads the Australasian KIDS DOSE consortium, a network of paediatric clinician-researchers across 17 hospital/research institutions in Australia and New Zealand, dedicated to improving equity in access to optimal antimicrobial use in children.
Associate Professor Amanda Gwee MBBS FRACP DTMH PhD is the Leader of the Antimicrobials Group at Murdoch Children's Research Institute. She is a general paediatrician, infectious diseases physician, clinical pharmacologist, and Clinical Lead of...
Associate Professor Amanda Gwee MBBS FRACP DTMH PhD is the Leader of the Antimicrobials Group at Murdoch Children's Research Institute. She is a general paediatrician, infectious diseases physician, clinical pharmacologist, and Clinical Lead of Research in the Department of General Medicine at The Royal Children’s Hospital Melbourne. In addition, she is an Associate Professor in the Department of Paediatrics, at the University of Melbourne.
Her research program focuses on optimising antimicrobial use and access in children and includes national and international clinical trials, pharmacokinetic/pharmacodynamic studies, and cohort studies. Amanda is passionate about improving medication use in children and is involved in several international guideline/expert groups (European Society for Paediatric Infectious Diseases, WHO, Therapeutic Guidelines). She created and leads the Australasian KIDS DOSE consortium, a network of paediatric clinician-researchers across 17 hospital/research institutions in Australia and New Zealand, dedicated to improving equity in access to optimal antimicrobial use in children.
Her research program focuses on optimising antimicrobial use and access in children and includes national and international clinical trials, pharmacokinetic/pharmacodynamic studies, and cohort studies. Amanda is passionate about improving medication use in children and is involved in several international guideline/expert groups (European Society for Paediatric Infectious Diseases, WHO, Therapeutic Guidelines). She created and leads the Australasian KIDS DOSE consortium, a network of paediatric clinician-researchers across 17 hospital/research institutions in Australia and New Zealand, dedicated to improving equity in access to optimal antimicrobial use in children.
Top Publications
- Boast, A, Zhang, W, Soeorg, H, Gonis, G, Di Carlo, A, Daley, A, Curtis, N, McWhinney, B, Ungerer, JPJ, Lei, A, et al. Population pharmacokinetic modeling of ceftriaxone in cerebrospinal fluid in children: should we be using once- or twice-daily dosing for meningitis?. Antimicrob Agents Chemother 68(11) : e0074724 2024 view publication
- McDonald, E, Pittet, LF, Barry, SE, Bonten, M, Campbell, J, Croda, J, Croda, MG, Dalcolmo, MP, Davidson, A, de Almeida E Val, FF, et al. Antecedent and persistent symptoms in COVID-19 and other respiratory illnesses: Insights from prospectively collected data in the BRACE trial.. J Infect 89(5) : 106267 2024 view publication
- Weerdenburg, H, Gwee, A, Haeusler, GM, Osowicki, J, Boast, A. Crushed posaconazole delayed-release tablets for antifungal prophylaxis and treatment in children.. J Antimicrob Chemother 2024 view publication
- O'Leary, C, Pittet, LF, Beaumont, R, Constable, L, Daley, A, Hodge, I, Jacobs, SE, King, A, Tan, C, Curtis, N, et al. Predictive performance of cerebrospinal fluid parameters for diagnosis of meningitis in infants: a cohort study.. Arch Dis Child 2024 view publication
- Phuong, LK, Cheung, A, Templeton, T, Abebe, T, Ademi, Z, Buttery, J, Clark, J, Cole, T, Curtis, N, Dobinson, H, et al. Epidemiology of childhood invasive pneumococcal disease in Australia: a prospective cohort study.. Arch Dis Child 2024 view publication
Page 1 of 22
Career information
Share //
